The Molecular Mechanism of Transforming Growth Factor-β Signaling for Intestinal Fibrosis: A Mini-Review
Inflammatory bowel disease is known as the most chronic inflammatory disorder in colon, which subsequently progresses to intestinal obstruction and fistula formation. Many studies to date for the treatment of IBD have been focused on inflammation. However, most of the anti-inflammatory agents do not...
Main Authors: | Sun-Mi Yun, Seok-Ho Kim, Eun-Hee Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00162/full |
Similar Items
-
Osteoglycin: An ECM Factor Regulating Fibrosis and Tumorigenesis
by: Jiayida Nulali, et al.
Published: (2022-11-01) -
Kurarinone Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting TGF-β Signaling Pathways
by: Soo-Jin Park, et al.
Published: (2021-08-01) -
Revisiting ameloblastin; addressing the EMT-ECM axis above and beyond oral biology
by: Janne E. Reseland, et al.
Published: (2023-11-01) -
Organ Fibrosis and Autoimmunity: The Role of Inflammation in TGFβ-Dependent EMT
by: Margherita Sisto, et al.
Published: (2021-02-01) -
Transforming growth factor-β-induced secretion of extracellular vesicles from oral cancer cells evokes endothelial barrier instability via endothelial-mesenchymal transition
by: Miho Kobayashi, et al.
Published: (2022-09-01)